AMICUS THERAPEUTICS, INC. — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2023-01-02

Reporting Person: Crowley John F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-02	Common Stock	F	21596	$12.21	Disposed	769858	Direct
2023-01-03	Common Stock	F	22116	$11.93	Disposed	747742	Direct
2023-01-03	Common Stock	A	233248	$0.00	Acquired	980990	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-03	Stock Options (right to buy)	$11.93	A	414025	Acquired	2033-01-03	Common Stock (414025)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	64895	Indirect

Footnotes

F1: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

F2: One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.